DiaMedica Therapeutics’ $16.4 Million Initial Public Offering

Ambrogio Visconti

Faegre Baker Daniels guided Craig-Hallum Capital Group as the sole managing underwriter on the offering DiaMedica Therapeutics Inc. (NASDAQ:DMAC) (TSX-V:DMA), a clinical stage biopharmaceutical company, priced…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now